GNNSF - Genscript Biotech GAAP EPS of -$10.82 revenue of $625.7M misses by $94.03M
2023-03-31 06:28:30 ET
- Genscript Biotech press release ( OTCPK:GNNSF ): FY GAAP EPS of -$10.82.
- Revenue of $625.7M (+27.7% Y/Y) misses by $94.03M .
- The adjusted net profit of non-cell therapy business before eliminations was approximately US$62.4 million, representing an increase of 31.4% as compared with approximately US$47.5 million for the year ended December 31, 2021,
For further details see:
Genscript Biotech GAAP EPS of -$10.82, revenue of $625.7M misses by $94.03M